购物车
- 全部删除
- 您的购物车当前为空
TopoisomeraseI/II inhibitor 8 (Compound Ru7) 是一种双催化抑制剂,能够损伤DNA并激活PARP-1,随后激活RIPK1、RIPK3和MLKL,从而引发坏死性凋亡 (necroptosis)。此化合物展现出显著的抗癌活性,通过坏死性凋亡靶向癌细胞的细胞核,在克服癌症耐药性上具备巨大临床潜力。
TopoisomeraseI/II inhibitor 8 (Compound Ru7) 是一种双催化抑制剂,能够损伤DNA并激活PARP-1,随后激活RIPK1、RIPK3和MLKL,从而引发坏死性凋亡 (necroptosis)。此化合物展现出显著的抗癌活性,通过坏死性凋亡靶向癌细胞的细胞核,在克服癌症耐药性上具备巨大临床潜力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 10-14周 | |
50 mg | 待询 | 10-14周 |
产品描述 | TopoisomeraseI/II inhibitor 8 (Compound Ru7) is a dual catalytic inhibitor of TopoisomeraseI/II that induces DNA damage and activates PARP-1, leading to the activation of RIPK1, RIPK3, and MLKL, ultimately causing necroptosis. It shows significant anticancer activity by effectively targeting cancer cell nuclei and inducing cell death through necroptosis, offering substantial clinical potential in overcoming resistance in cancer treatment. |
分子量 | 497.179 |
分子式 | C14H11Br2NO5S2 |
CAS No. | 355400-87-2 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容